RE-BVS – Piemonte Repository

Sfoglia per AUTORE
POTTER V
Collezione AOU Città della Salute di Torino

Items : 5

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). in Bone marrow transplantation / Bone Marrow Transplant. 2022 Dec;57(12):1803-1809. doi: 10.1038/s41409-022-01830-3. Epub 2022 Sep 22

2022
AOU Città della Salute di Torino

Bazarbachi A; Giebel S; Savani B; Anagnostopoulos A; Ozdogu H; Sanz J; Busca A; Zuckerman T; Mielke S; Kröger N; Hilgendorf I; Rambaldi A; Berceanu A; Potter V; Yakoub-Agha I; Salmenniemi U; Sakellari I; Gavriilaki E; Labopin M; Spyridonidis A; Nagler A; Mohty M;

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Sep;56(9):2194-2202. doi: 10.1038/s41409-021-01317-7. Epub 2021 Apr 30.

2021
AOU Città della Salute di Torino

Brissot E; Ruggeri A; Sanz J; Diez-Martin JL; Blaise D; Benedetti F; Zuckerman T; Tischer J; Schmid C; Potter V; Kuball J; Caballero D; Brecht A; Angelucci E; Valerius T; Niittyvuopio R; Labussière-Wallet H; Gedde-Dahl T; Bornhäuser M; Bruno B; Finke J; Bazarbachi A; Ciceri F; Labopin M; Kharfan-Dabaja MA; Savani BN; Giebel S; Nagler A; Mohty M; et alii...

Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. in Frontiers in immunology / Front Immunol. 2021 Dec 21;12:813838. doi: 10.3389/fimmu.2021.813838. eCollection 2021.

2021
AOU Città della Salute di Torino

Kröger N; Lee SJ; Hayden P; Schaap N; Ljungman P; Potter V; Massalski C; Lange V; Onida F; Bruno B; van Gelder M; Spellman S; de Wreede LC; Heidenreich F; Kuxhausen M; Koster L; Schetelig J; Baldauf H; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M;

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. in Frontiers in immunology / Front Immunol. 2021 Jan 19;11:584520. doi: 10.3389/fimmu.2020.584520. eCollection 2020.

2020
AOU Città della Salute di Torino

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2016 Sep;22(9):1615-1620. doi: 10.1016/j.bbmt.2016.05.026. Epub 2016 J

2016
AOU Città della Salute di Torino

Bruno B; Socié G; Russell NH; Fegueux N; Lenhoff S; Craddock C; Ljungman P; Cahn JY; Huynh A; Chalandon Y; Chevallier P; Bay JO; Tabrizi R; Yakhoub-Agha I; Passweg JR; Maertens J; Bourhis JH; van Biezen A; Iacobelli S; Potter VT; Meijer E; Mufti GJ; de Witte T; Robin M; Kröger N;